Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 19, 2009Clinical Journal of the American Society of NephrologyOpen Access

Intradialytic Administration of Daptomycin in End Stage Renal Disease Patients on Hemodialysis

View Full Paper
Ask AI
Bookmark
Share

Authors

NSNoha N. SalamaUniversity of Maryland, BaltimoreJSJonathan H. SegalUniversity of MichiganMCMariann D. ChurchwellUniversity of Toledo

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Salama et al. (2009) studied this question.

synapsesocial.com/papers/6a70779b660549caf2c50dc6https://doi.org/10.2215/cjn.01650309
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pharmacokinetics and Tolerability of Daptomycin at Doses up to 12 Milligrams per Kilogram of Body Weight Once Daily in Healthy Volunteers2006 · 325 citations
  2. 2Effects of Dialysis Membrane on Intradialytic Vancomycin Administration1997 · 32 citations
  3. 3Comparison of 3 vancomycin dosage regimens during hemodialysis with cellulose triacetate dialyzers: post-dialysis versus intradialytic administration2003 · 39 citations
  4. 4Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptide antibiotic, in healthy volunteers1992 · 158 citations
  5. 5Population Pharmacokinetics of Daptomycin2004 · 154 citations